TRIAL N. | STATUS | N. PATIENT | CONDITION | COMPOUND | FUNCTION | PHASE |
NCT03395704 | Completed | 70 | Haemocromatosis | LJPC-401 | Synthetic human hepcidin | Phase II |
NCT03381833 | Terminated | 84 | Beta-Thalassemia | LJPC-401 | Sintetic human hepcidin | Phase II |
NCT04057040 | Active not recruiting | 80 | Policitemia vera | PTG 300 | Hepcidin mimetic | Phase II |
NCT06033586 | Not yet recruiting | 50 | Policitemia vera | PTG 300 | Hepcidin mimetic | PhaseIII |
NCT04767802 | Active, not recruiting | 20 | Policitemia vera | PTG 300 | Hepcidin mimetic | Phase II |
NCT04054921 | Completed | 34 | β-thalassemia Ineffective Erythropoiesis | PTG300 | Hepcidin mimetic | Phase II |
NCT05210790 | Recruiting | 250 | Policitemia vera | PTG 300 | Hepcidin mimetic | Phase III |
NCT02340572 | Completed | 48 | Healthy | PRS-080 | Hepcidin blocker | Phase I |
NCT03325621 | Completed | 11 | Anemia of Chronic Kidney Disease | PRS-080 | Hepcidin blocker | Phase I-II |
NCT02754167 | Unknown | 24 | Anemia of Chronic Kidney Disease | PRS-080 | Hepcidin blocker | Phase I-II |
NCT05499013 | Recruiting | 65 | Policitemia Vera | SLN124 | Anti TMPRSS 6 | Phase I-II |
NCT03165864 | Completed | 36 | Thalassemia | IONIS TMPRSS6-Lrx | Anti TMPRSS 6 | Phase I |
NCT05077436 | Completed | 28 | Healthy | Vamifeport | AntiFPN | Phase I |
NCT04817670 | Recruiting | 24 | Sickle Cell Disease | Vamifeport (VIT 2763) | Anti FPN | Phase II |
NCT04364269 | Completed | 25 | Beta-Thalassemia | Vamifeport (VIT 2763) | Anti FPN | Phase II |
NCT04938635 | Withdrawn | 0 | Beta-Thalassemia | Vamifeport (VIT 2763) | AntiFPN | Phase II |
NCT04707261 (ADIDAS) | Recruiting | 1990 | Anemia Heart Failure | Dapaglifozin | Reduction hepcidin pathwhay | Phase IV |